TP53 and prostate carcinoma: However, under the conditions used here, no direct interaction with either p/CAF, p53 or TRAF3 and TRAF6—i.e., factors previously shown to bind to MYSM1 in prostate cancer cells or immune cells, respectively, [31,45,51]—were detected.